Here’s What You WON’T Hear From Corporate Media About The Monkeypox Outbreak By Matt Agorist for The Free Thought Project
When Dr. Anthony Fauci screamed at Sen. Rand Paul (R-KY) in July of 2021 — calling him a liar for accusing him of funding so-called “Gain-of-Function” (GoF) research in Wuhan, China to make coronaviruses more transmissible to humans, the argument ultimately faded due to Fauci’s unsupported claim that the research didn’t technically fit the definition of GoF.
However, thanks to documents released through a Freedom of Information Act lawsuit by The Intercept against the National Institutes of Health found (here and here), we now know that the Fauci-funded EcoHealth Alliance, a New York-based nonprofit headed by Peter Daszak, was absolutely engaged in gain-of-function research to make chimeric SARS-based coronaviruses, which they confirmed could infect human cells.
Anyone who spoke about this information in 2020 was unceremoniously wiped from the internet by the gatekeepers of information within Big Tech only to be proven right the following year. The world finally knew that the most plausible theory for the origination of COVID-19 was not bats in an open-air market but rather a lab in Wuhan, China.
Now is your chance to support Gospel News Network.
We love helping others and believe that’s one of the reasons we are chosen as Ambassadors of the Kingdom, to serve God’s children. We look to the Greatest Commandment as our Powering force.
Corporate media and the establishment would be forced to reckon with their past censorship of this theory yet no one was ever held accountable, and as the following study proves, the lab in Wuhan is still at it.
Currently, you cannot turn on a television, sign on to social media, or browse the internet without seeing the hysteria over monkeypox. If you were to believe the legacy media, you would think that monkeypox is spreading like wildfire and it is only a matter of time before you catch it.
The US has purchased 13 million doses of a monkeypox vaccine from Bavarian Nordic for $119 million, sending their stock prices skyrocketing. “Health experts” arealready taking to their pulpits to fan the flames of unhinged fear about the disease. However, in the last ten days, countries across the planet have reported just 92 confirmed cases and 28 suspected cases of this disease — out of 7.9 billion people.
What’s more, monkeypox has been around for decades, is not airborne, it is not novel and we know how to respond to it, treat it, and prevent it.
Monkeypox is “not as highly transmissible as something like smallpox, or measles, or certainly not COVID,” Anne Rimoin, an infectious disease epidemiologist at the University of California Los Angeles, told Vox.
The fact that monkeypox is not nearly as dangerous as smallpox or COVID is certainly comforting, but when we look at a recent study published from the infamous Wuhan laboratory in February of 2022 and other coincidental incidents, the comfort wanes swiftly.
The study, titled, Efficient assembly of a large fragment of monkeypox virus genome as a qPCR template using dual-selection based transformation-associated recombination,was first published just months before the international outbreak of monkeypox and it began in 2021. Researchers at the Wuhan Institute of Virology published the study in the peer reviewed journal Virologica Sinica.
According to a report from the National Pulse, researchers in the study were working on ways to manipulate the monkeypox virus using methods that have been flagged for creating “Contagious Pathogens”:
Researchers appeared to identify a portion of the monkeypox virus genome, enabling PCR tests to identify the virus, in the paper: “Efficient Assembly of a Large Fragment of Monkeypox Virus Genome as a qPCR Template Using Dual-Selection Based Transformation-Associated Recombination.”
Monkey pox viruses – referred to as “MPXVs” in the paper – have strains that are “more pathogenic and [have] been reported to infect humans in various parts of the world.”
“Quantitative polymerase chain reaction (qPCR) is the gold standard for the detection of orthopoxvirus (including MPXV). For pan-orthopoxviruses detection, the E9L (DNA polymerase) gene has been shown to be an excellent target for qPCR assays. For MPXV detection, Li et al. reported that the C3L (complement-binding protein) gene could be used as the qPCR target for the MPXV Congo Basin strain,” explained the paper before noting that China lacked sufficient genetic information on the virus for PCR detection:
“Since MPXV infection has never been associated with an outbreak in China, the viral genomic material required for qPCR detection is unavailable. In this report, we employed dual-selective TAR to assemble a 55-kb MPXV genomic fragment that encompasses E9L and C3L, two valuable qPCR targets for detecting MPXV or other orthopoxviruses.”
“The primary purpose of assembling a fragment of the MPXV genome is to provide a nucleotide template for MPXV detection,” reiterated the study, which relied on the process of transformation-associated recombination (TAR) to isolate a genomic fragment of the monkeypox virus.
The paper acknowledged that TAR “applied in virological research could also raise potential security concerns, especially when the assembled product contains a full set of genetic material that can be recovered into a contagious pathogen.”
“In this study, although a full-length viral genome would be the ideal reference template for detecting MPXV by qPCR, we only sought to assemble a 55-kb viral fragment, less than one-third of the MPXV genome. This assembly product is fail-safe by virtually eliminating any risk of recovering into an infectious virus while providing multiple qPCR targets for detecting MPXV or other Orthopoxviruses,” posited researchers.
Investigative journalist Sharyl Attkisson cites MedPage research that suggests that the monkeypox virus may have an increased transmissibility.
